Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Cancer news

Show

From To
Men with HPV are 20 times more likely to be reinfected after one year

An analysis of HPV in men shows that infection with one type strongly increased the risk of reinfection of the same type. The study highlights the importance of vaccination for preventing the spread of HPV in young men before they become sexually active and in older men who have already contracted the virus.

Published
06 December 2017
From
Eurekalert Inf Dis
New Cancer Management Guidelines for Care of People with Kaposi Sarcoma

National Comprehensive Cancer Network releases new Guidelines for best practices for treating patients with kaposi sarcoma

Published
04 December 2017
From
Poz
ART reduces prevalence of cervical infection with high-risk HPV, pre-cancerous cell changes and cervical cancer

Antiretroviral therapy (ART) is associated with a lower prevalence of high-risk cervical human papillomavirus (HPV) infection in women with HIV, according to the results of a meta-analysis published

Published
04 December 2017
By
Michael Carter
Bristol-Myers Cancer Drug Opdivo Shows Surprising HIV Impact

Bristol-Myers Squibb Co.’s blockbuster drug Opdivo had a stunning effect on a lung-cancer patient treated at a Paris hospital: it drained hard-to-reach reservoirs of his HIV infection, too.

Published
01 December 2017
From
Bloomberg
People living with HIV can live longer, but urgently need improved care to achieve better health outcomes and quality of life

Experts unveiled a set of recommendations on Wednesday to address health problems facing people living with HIV. Treatments are helping people with HIV live long lives, but they face higher risk than others of serious illnesses – from cancer to heart disease to depression.

Published
29 November 2017
From
HIV Outcomes
Screen all HIV-positive MSM for pre-cancerous anal cell changes, say Dutch investigators

Younger age and shorter duration of viral suppression are risk factors for the development of high-grade pre-cancerous anal lesions in HIV-positive men who have sex

Published
15 November 2017
By
Michael Carter
Nivolumab improves outcomes in liver cancer study

Nivolumab (Opdivo), a PD-1 checkpoint inhibitor that helps the immune system fight cancer, was associated with a decrease in tumour size or disease stabilisation in people with hepatocellular

Published
14 November 2017
By
Liz Highleyman
For cancer patients with HIV, immunotherapy appears safe

Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials

Published
08 November 2017
From
Fred Hutch
European AIDS Clinical Society strengthens HPV vaccination advice

The European AIDS Clinical Society (EACS) has recommended HPV (human papillomavirus) vaccination for everyone living with HIV aged under 26 and all men who have

Published
08 November 2017
By
Keith Alcorn
ART reduces HPV, cervical cancer in women with HIV

Women with HIV on ART had a lower prevalence of high-risk HPV infection, high-grade cervical lesions and invasive cervical cancer than women who were not receiving ART, according to results of a recent meta-analysis.

Published
06 November 2017
From
Healio
← First12345...47Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.